United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

amarox ltd - eprosartan mesilate - oral tablet - 600mg

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

manx healthcare ltd - eprosartan mesilate - oral tablet - 300mg

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

manx healthcare ltd - eprosartan mesilate - oral tablet - 400mg

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

manx healthcare ltd - eprosartan mesilate - oral tablet - 600mg

Ireland - English - HPRA (Health Products Regulatory Authority)

bgp products ltd - eprosartan mesylate - film coated tablet - 400 milligram - angiotensin ii antagonists, plain - angiotensin-ii antagonists, plain c - eprosartan is indicated for the treatment of essential hypertension.

Ireland - English - HPRA (Health Products Regulatory Authority)

bgp products ltd - eprosartan mesylate - film coated tablet - 600 milligram - angiotensin ii antagonists, plain - angiotensin-ii antagonists, plain c - eprosartan is indicated for the treatment of essential hypertension

Malta - English - Medicines Authority

mylan ire healthcare limited unit 35/36, grange parade, baldoyle industrial estate, dublin 13, ireland - eprosartan - film-coated tablet - eprosartan 600 mg - agents acting on the renin-angiotensin system

United States - English - NLM (National Library of Medicine)

physicians total care, inc. - eprosartan mesylate (unii: 8n2l1nx8s3) (eprosartan - unii:2kh13z0s0y), hydrochlorothiazide (unii: 0j48lph2th) (hydrochlorothiazide - unii:0j48lph2th) - eprosartan 600 mg - teveten® hct is indicated for the treatment of hypertension. it may be used alone or in combination with other antihypertensives such as calcium channel blockers. this fixed dose combination is not indicated for initial therapy (see dosage and administration ). teveten® hct is contraindicated in patients who are hypersensitive to this product or any of its components. because of the hydrochlorothiazide component, this product is contraindicated in patients with anuria or hypersensitivity to other sulfonamide-derived drugs.

Ireland - English - HPRA (Health Products Regulatory Authority)

bgp products ltd - eprosartan mesylate, hydrochlorothiazide - film coated tablet - 600/12.5 milligram - eposartan and diuretics - angiotensin-ii antagonists, plain c - essential hypertension it is indicated in patients whose blood pressure is not adequately controlled on eprosartan alone.

Ireland - English - HPRA (Health Products Regulatory Authority)

mylan ire healthcare limited - eprosartan; hydrochlorothiazide - film-coated tablet - 600/12.5 milligram(s) - angiotensin ii antagonists and diuretics; eprosartan and diuretics